Payal Kohli
Internal Medicine · Aurora, CO
CMS Profile ID: 110638 · NPI: 1447459771
Total Disclosed General Payments
$522,837.65
General-payment records
498
CMS Program Year
2025
Most of this (about 68%) was payments for services other than consulting, including faculty or speaking services outside continuing education.
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,540.20 |
| Consulting Fee | $103,229.11 |
| Travel and Lodging | $53,413.92 |
| Food and Beverage | $8,654.42 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $152,772.78 |
| Lilly USA, LLC | $101,245.34 |
| Amgen Inc. | $98,177.48 |
| Novo Nordisk Inc | $46,611.05 |
| E.R. Squibb & Sons, L.L.C. | $35,423.33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25,823.73 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1447459771 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1447459771.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.